DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748305. A total of 22 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,000 | -90.2% | 20,500 | -79.5% | 0.00% | – |
| Q3 2021 | $51,000 | -30.1% | 100,000 | 0.0% | 0.00% | – |
| Q2 2021 | $73,000 | -20.7% | 100,000 | -0.0% | 0.00% | – |
| Q1 2021 | $92,000 | +187.5% | 100,050 | +150.1% | 0.00% | – |
| Q4 2020 | $32,000 | -5.9% | 40,000 | 0.0% | 0.00% | – |
| Q3 2020 | $34,000 | – | 40,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 89,848 | $27,000 | 0.31% |
| Virtu Financial LLC | 151,310 | $46,000 | 0.01% |
| Frontier Wealth Management LLC | 25,000 | $8,000 | 0.00% |
| Strategic Asset Management, LLC | 2,000 | $1,000 | 0.00% |
| JANE STREET GROUP, LLC | 22,726 | $7,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 7,145 | $2,000 | 0.00% |
| NORTHERN TRUST CORP | 200,949 | $61,000 | 0.00% |
| St. Johns Investment Management Company, LLC | 2 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 52,652 | $16,000 | 0.00% |